Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-SARS-CoV-2 S2 Protein (CV3-25)

Catalog #:   DVV00502 Specific References (10) DATASHEET
Host species: Human
Isotype: IgG1
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DVV00502

Expression system

Mammalian Cells

Species reactivity

SARS-CoV-2(2019-nCoV)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P0DTC2

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

CV3-25

Data Image
References

Structure and inhibition of SARS-CoV-2 spike refolding in membranes., PMID:39146425

Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD., PMID:36514310

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit., PMID:35411021

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses., PMID:35216664

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection., PMID:35123652

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells., PMID:35062211

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern., PMID:34971573

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern., PMID:34373853

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects., PMID:34237283

Magnitude and reliability of mechanical outputs obtained during loaded squat jumps performed from different knee angles., PMID:31232220

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1314

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-SARS-CoV-2 S2 Protein (CV3-25) [DVV00502]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only